Notes
2016 US dollars
Reference
Li Q, et al. Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years. Diabetes Therapy 9: 1279-1293, No. 3, Jun 2018. Available from: URL: http://doi.org/10.1007/s13300-018-0432-2
Rights and permissions
About this article
Cite this article
Liraglutide cost saving versus sitagliptin for T2DM. PharmacoEcon Outcomes News 806, 15 (2018). https://doi.org/10.1007/s40274-018-5058-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5058-0